Q&A with Daniel Drucker
Med discusses the history and future of GLP-1 research with Professor Daniel Drucker from the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto, Canada.
Related Articles
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery:
AbstractBackgroundCurrent guidelines recommend the perioperative continuation of aspirin in patients with coronary drug-eluting stents (DES) undergoing noncardiac surgery. However, supporting evide…
In rural America, heart disease is increasingly claiming younger lives
People living in rural parts of the country live shorter lives, on average, than their urban counterparts, largely due to heart disease. That disparity grew…
Innovation is the true driving force for changing the world, says chemist Josep Cornella
How to create impactful science that drives meaningful change with Dr. Cornella.
Even inside holiday desserts, can apples help keep the doctor away?
No matter the variety, apples have loads of benefits for heart health. Here’s how to keep them healthy as you prepare for holiday celebrations.
Remote Monitoring Can Transform Chronic Disease Care for Rural Americans: A Call to Action for Medicare
The United States is facing a looming public health crisis stemming from a shortage of primary care physicians as the prevalence of chronic disease continues…
Efficacy of early use of percutaneous stellate ganglion block for electrical storms
AbstractAims. Electrical storm (ES) is a life-threatening condition requiring a rapid management. Percutaneous stellate ganglion block (PSGB) is proved to
Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More
The reason for the disparity is unknown but is not believed to be genetic. Female athletes appear to be at the lowest risk.
More Surgical Team Familiarity Could Trim Cardiopulmonary Bypass Time
While no impacts were seen on morbidity or mortality, the data provide evidence to the theory that “familiarity breeds success.”
PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits
The new data may spark fresh debate over alcohol’s once-celebrated cardioprotective benefits: not everyone is convinced.